ADTX: Aditxt Corp Growth-Adjusted Market Cap to Net Income

Brandmark of Aditxt (ADTX)

A lack of pricing power and a dependence on share issuance are putting critical pressure on Aditxt (ADTX) quotes. This PEG ratio chart demonstrates market volatility, where 0.00 expresses the metric's current value. Business stability depends on attracting investments in health mapping, while the success of immunology developments remains independent of macroeconomics, providing resilience against downturns.

ADTX Aditxt Inc.: Price/Earnings to Growth Ratio in the range 07/04/2022 - 07/11/2026
Signature product of Aditxt Inc.

The PEG ratio correlates the current P/E multiple with earnings growth rates, allowing for the determination of an asset's fair value relative to its expansion: a value below one signals an undervaluation of growth potential. For Aditxt (ADTX), this calculation is critical, as the scalability of the diagnostic IT platform reduces costs and increases margins, which is clearly reflected in the historical P/E-to-growth price action.

Competing companies

ARGX (argenx N.V.) - Growth-Adjusted Payback Ratio|PEG Multiple BNTX (BioNTech Group)|Growth-Adjusted Market Cap to Net Income Abivax (ABVX)|ADMA - Price/Earnings to Growth Ratio|protagonist-inc.com (PTGX) - Price/Earnings to Growth Multiple|Immunovant (IMVT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Kiniksa Pharmaceuticals, Ltd.|Price/Earnings to Growth Multiple GRFS|PEG Multiple Adaptive Biotechnologies Inc.|Price/Earnings to Growth Ratio Celldex Therapeutics (CLDX)|auriniapharma.com - Growth-Adjusted P/E Ratio|PEG Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Price to Earnings Adjusted for Growth Rate|Dianthus Pharma - PEG Multiple|PHVS - PEG Multiple|ABCL: PEG Multiple|Growth-Adjusted P/E Ratio TRML|PGEN (Precigen) - PEG Multiple|Pharming Group NV (PHAR) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple NKTR (Nektar)|Company Value to Earnings Growth Ratio UPB|Zenas Biopharma Inc - Price/Earnings to Growth Multiple|IMNM: Growth-Adjusted P/E Ratio|GOSS: Price/Earnings to Growth Multiple|KalVista Pharma - Company Value to Earnings Growth Ratio|SEPN: PEG Multiple|Pieris Corp (PVLA) - PEG Multiple|SVRA (Savara Inc.) - PEG Multiple|Growth-Adjusted P/E Ratio RIGL (rigel.com)|Price/Earnings to Growth Multiple ANAB (AnaptysBio)|Company Value to Earnings Growth Ratio ATXS|enGene Bio - Price/Earnings to Growth Multiple|RAPT: Growth-Adjusted P/E Ratio|JBIO - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio ACRS|KYTX: PEG Multiple|Tiziana Life Sciences Ltd. - Growth-Adjusted Payback Ratio|CABA (Cabaletta Bio, Inc) - PEG Multiple|PEG Multiple Ventyx Biosciences, Inc|Price/Earnings to Growth Ratio Theratechnologies Inc. (THTX)|AVTX (avalotx.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Eledon Pharmaceuticals, Inc. ELDN|AGEN - Price/Earnings to Growth Multiple|Climb Bio, Inc. - PEG Multiple|ZURA - PEG Multiple|ATYR (aTyr Pharma, Inc.) - Price/Earnings to Growth Multiple|Adagene Inc. - Growth-Adjusted Payback Ratio|IMA (ImageneBio) - PEG Multiple|Shattuck Therapeutics (STTK) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Equillium, Inc. (EQ)|Price/Earnings to Growth Multiple connectbiopharm.com CNTB|Price/Earnings to Growth Ratio Immunic IMUX|ATRA - Price/Earnings to Growth Multiple|IFRX: Price/Earnings to Growth Multiple|XFOR - PEG Multiple|adicetbio.com (ACET) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio CELU|INMB (INmune Bio, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate barinthusbio.com BRNS|PEG Multiple KZR|PEG Multiple SAB Biotherapeutics Inc. (SABS)|PEG Multiple AKTX (Akari Therapeutics plc)|ENLV: Growth-Adjusted P/E Ratio|Q32 Bio Corp - PEG Multiple|Growth-Adjusted Market Cap to Net Income geovax.com GOVX|EDSA (Edesa Biotech) - Price/Earnings to Growth Multiple|IBIO: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple CARM|Growth-Adjusted P/E Ratio XTLB (XTL Bio)|Price/Earnings to Growth Multiple BOLT (Bolt Biotherapeutics)|Company Value to Earnings Growth Ratio HCWB|PEG Multiple APVO (Aptevo Therapeutics Inc.)|PEG Multiple aimimmuno.com AIM|GRI Bio Corp - PEG Multiple|XRTX (XORTX Corp) - Growth-Adjusted P/E Ratio|HIND (Vyome Holdings Inc) - Price/Earnings to Growth Multiple|REVB: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple INDP|Growth-Adjusted P/E Ratio SCNI (Scinai Immunotherapeutics Ltd)|Price/Earnings to Growth Ratio CalciMedica, Inc. (CALI)|AFMD: Market Cap to Earnings and Growth Ratio|PEG Multiple ALLK (Allakos)|Growth-Adjusted Payback Ratio HOOK|IGM Bio - PEG Multiple|ITOS - PEG Multiple|Ocean Bio (OCEA) - Price/Earnings to Growth Ratio|TC BioPharm Ltd - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Third Harmonic Bio